Medical Properties Trust, Inc. (MPW)
NYSE: MPW · Real-Time Price · USD
5.48
-0.13 (-2.32%)
At close: Dec 5, 2025, 4:00 PM EST
5.60
+0.12 (2.19%)
After-hours: Dec 5, 2025, 7:56 PM EST
Medical Properties Trust Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Medical Properties Trust stock have an average target of 5.42, with a low estimate of 4.00 and a high estimate of 9.00. The average target predicts a decrease of -1.09% from the current stock price of 5.48.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Medical Properties Trust stock from 6 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 1 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 7 | 7 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Sell Maintains $4.5 → $5 | Sell | Maintains | $4.5 → $5 | -8.76% | Nov 25, 2025 |
| Wells Fargo | Wells Fargo | Sell Maintains $5 → $4.5 | Sell | Maintains | $5 → $4.5 | -17.88% | Aug 27, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $5 → $4.5 | Hold | Maintains | $5 → $4.5 | -17.88% | Jun 30, 2025 |
| Exane BNP Paribas | Exane BNP Paribas | Hold → Buy Upgrades $5 → $9 | Hold → Buy | Upgrades | $5 → $9 | +64.23% | Mar 12, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $4 → $5 | Hold | Maintains | $4 → $5 | -8.76% | Mar 10, 2025 |
Financial Forecast
Revenue This Year
941.34M
from 1.04B
Decreased by -9.37%
Revenue Next Year
1.02B
from 941.34M
Increased by 8.36%
EPS This Year
-0.29
from -4.02
EPS Next Year
0.14
from -0.29
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 1.0B | 1.1B | ||||
| Avg | 941.3M | 1.0B | ||||
| Low | 881.8M | 913.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.9% | 17.5% | ||||
| Avg | -9.4% | 8.4% | ||||
| Low | -15.1% | -2.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.16 | 0.21 | |
| Avg | -0.29 | 0.14 | |
| Low | -0.47 | 0.07 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.